Trexquant Investment’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-140,325
| Closed | -$2.08M | – | 1679 |
|
2024
Q1 | $2.08M | Buy |
+140,325
| New | +$2.08M | 0.04% | 635 |
|
2023
Q2 | – | Sell |
-280,846
| Closed | -$1.72M | – | 1599 |
|
2023
Q1 | $1.72M | Buy |
280,846
+104,220
| +59% | +$637K | 0.05% | 514 |
|
2022
Q4 | $1.13M | Buy |
+176,626
| New | +$1.13M | 0.03% | 606 |
|
2022
Q1 | – | Sell |
-13,657
| Closed | -$261K | – | 1532 |
|
2021
Q4 | $261K | Sell |
13,657
-9,995
| -42% | -$191K | 0.02% | 1001 |
|
2021
Q3 | $583K | Buy |
+23,652
| New | +$583K | 0.05% | 477 |
|
2021
Q2 | – | Sell |
-34,757
| Closed | -$1.1M | – | 1286 |
|
2021
Q1 | $1.1M | Buy |
+34,757
| New | +$1.1M | 0.1% | 253 |
|
2020
Q4 | – | Sell |
-16,733
| Closed | -$551K | – | 1245 |
|
2020
Q3 | $551K | Sell |
16,733
-31,137
| -65% | -$1.03M | 0.04% | 638 |
|
2020
Q2 | $1.31M | Buy |
+47,870
| New | +$1.31M | 0.09% | 312 |
|
2019
Q2 | – | Sell |
-55,079
| Closed | -$524K | – | 964 |
|
2019
Q1 | $524K | Buy |
+55,079
| New | +$524K | 0.04% | 576 |
|
2018
Q4 | – | Sell |
-24,732
| Closed | -$278K | – | 1157 |
|
2018
Q3 | $278K | Buy |
24,732
+14,618
| +145% | +$164K | 0.02% | 708 |
|
2018
Q2 | $129K | Buy |
+10,114
| New | +$129K | 0.01% | 825 |
|
2018
Q1 | – | Sell |
-15,464
| Closed | -$124K | – | 1220 |
|
2017
Q4 | $124K | Sell |
15,464
-24,126
| -61% | -$193K | 0.01% | 994 |
|
2017
Q3 | $307K | Buy |
+39,590
| New | +$307K | 0.08% | 458 |
|
2017
Q2 | – | Sell |
-26,449
| Closed | -$197K | – | 956 |
|
2017
Q1 | $197K | Buy |
+26,449
| New | +$197K | 0.03% | 964 |
|
2016
Q4 | – | Sell |
-14,652
| Closed | -$121K | – | 1040 |
|
2016
Q3 | $121K | Buy |
+14,652
| New | +$121K | 0.03% | 681 |
|
2016
Q2 | – | Sell |
-27,660
| Closed | -$141K | – | 970 |
|
2016
Q1 | $141K | Buy |
+27,660
| New | +$141K | 0.02% | 861 |
|